Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,435.00 GBX | -1.00% |
|
-5.78% | +6.57% |
Jun. 18 | Kennedy's new US vaccine panel to discuss measles shot for children | RE |
Jun. 18 | Kennedy's new US vaccine panel to discuss measles shot for children | RE |
Main competitors
1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility (Composite) | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|
19 | ||||||||
27 | ||||||||
23 | ||||||||
22 | ||||||||
27 | ||||||||
20 | ||||||||
19 | ||||||||
20 | ||||||||
24 | ||||||||
28 | ||||||||
23 | ||||||||
26 | ||||||||
23 | ||||||||
28 | ||||||||
22 | ||||||||
14 | ||||||||
16 | ||||||||
16 | ||||||||
17 | ||||||||
Average | 22 | |||||||
Weighted average by Cap. | 23 |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions